Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Insider trades › Elanco › Director reported a gift or transfer of 60K ELAN shares Insider trades
Why it stands out Gift or transfer — classified separately from trades.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Transaction date Dec 19, 2025
Reporting period Not applicable
Filed with the SEC Dec 23, 2025 Director Indirect holding Gift / transfer
Context Classification gift transfer
Code G — gift, bequest or transfer
Planned / mechanical clue None found in footnotes
Only flagged when a footnote says so; never inferred
0001186033-25-000007
Filed / recorded Dec 23, 2025, 9:03 PM UTC
Added to OQRO Oct 6, 2026, 7:37 PM UTC
Data quality Verified: identifiers matched exactly
Issuer Elanco Animal Health Inc
Reporting person R David Hoover
Table Non-derivative (Table I)
Transaction date Dec 19, 2025
Acquired / disposed Disposed (D)
Shares owned after 150,000
Ownership form Indirect — Revocable Trust
Footnotes from the filing Reported transaction is a gift of shares to a charitable trust.
Around the same time Fund moves
14 tracked managers disclosed the same change for Q4 2025. From a 13F filed Jan 22, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Insider filing
Traded Jan 9 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jan 9 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Oct 31, 2025 Company filing · Form 8-K · Material agreement, New debt Signed an important agreement, and took on new debt or obligations Nov 5, 2025 Company filing · Form 8-K · Results Reported its results Dec 5, 2025 Company filing · Form 8-K · Restructuring, Reg FD Announced job cuts, closures or a restructuring, and shared information with investors “On December 5, 2025, the Board of Directors of Elanco Animal Health Incorporated (the “Company”) authorized a restructuring plan with respect to its workforce (the “Restructuring Plan”) to support margin expansion, optimize the Company’s footprint, and further invest in innovation.” Dec 11, 2025 Insider · 2 people Insiders: 2 purchases (~$629K) Dec 12, 2025 Insider · 3 insiders in a week, 7th time since 2018 Director purchased ~$213K of ELAN shares in the open market What came next Feb 24, 2026 Company filing · Form 8-K · Results Reported its results